CSE Bulletin: MOC Eligibility Update

On November 27, 2025, the Canadian Securities Exchange (CSE) announced an important update regarding Market-on-Close (MOC) eligibility for a number of listed symbols. Effective December 2, 2025, the following companies will gain MOC eligibility, allowing them to participate in orders that execute at the closing price of the trading session. The new MOC-eligible symbols span diverse industries, including technology, mining, pharmaceuticals, and agriculture.

Among the companies now eligible for MOC orders are Adelayde Exploration Inc. (ADDY), Algernon Health Inc. (AGN), and Genesis AI Corp. (AIG). Other notable additions include BioMark Diagnostics Inc. (BUX), Supreme Critical Metals Inc. (CRIT), and Cult Food Science Corp (CULT). The range of sectors showcased by these companies reflects the CSE's broad market coverage, particularly in biotechnology and precious metals.

Investors will now have the opportunity to execute MOC orders for a total of 75 symbols, bolstering their capacity to manage closing prices effectively and enhance trading strategies. The CSE is maintaining a commitment to improving market functionality for its listed companies, as seen through the integration of MOC capabilities for these symbols.

For a complete list of MOC-eligible symbols and further details, market participants can refer to the CSE website under their trading resources section. The CSE also encourages inquiries through its Market Operations contact details for any assistance regarding this development.

This update signifies an essential enhancement for CSE-listed companies, potentially leading to increased liquidity and improved trading efficacy as investors leverage the advantages of Market-on-Close orders.

As of December 2, 2025, several new symbols will be eligible for Market-on-Close (MOC) trading on the Canadian Securities Exchange (CSE). This update presents numerous opportunities for traders and investors to consider, particularly in the context of the emerging sectors represented by these companies.

MOC eligibility can enhance liquidity and provide a more efficient trading mechanism, especially for stocks that are more volatile or less actively traded. Noteworthy among the newly listed companies are several in high-growth sectors, such as biotechnology (Bright Minds Biosciences Inc. and Rapid Dose Therapeutics Corp) and exploration (Adelayde Exploration Inc. and Canary Gold Corp). Investors might want to keep a close eye on these firms as they could capitalize on the demand for innovative solutions and natural resources in a recovering market, post-pandemic.

For those considering investments, it is crucial to conduct thorough due diligence. Evaluate the fundamentals of each company—their market capitalization, earnings potential, and growth strategy. Additionally, particularly with the biotech sector, it is important to consider the regulatory environment and clinical trial outcomes, which can significantly affect stock prices.

Moreover, evaluating Canadian market trends and global economic indicators will also be pivotal, as commodities, especially in mining and energy, could see heightened activity due to ongoing shifts in supply and demand. Resource interests, as highlighted by companies such as Nuclear Vision Limited and Sparc AI Inc., might attract strategic investments, particularly as countries focus on sustainability.

In conclusion, the introduction of these MOC-eligible companies provides a fresh landscape for traders. By leveraging the enhanced trading environment of MOC along with careful analysis of sector fundamentals, investors can position themselves to benefit from both short-term market movements and long-term growth potential in these dynamic industries.